Upgrade to SI Premium - Free Trial

Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at H.C. Wainwright

August 18, 2026 12:28 PM
H.C. Wainwright analyst Andrew Fein raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $55.00 (from $34.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change